These therapies and interventions include obesity reduction by weight loss and bariatric surgery, antidiabetic agents (particularly GLP-1R agonists and SGLT2 inhibitors), and statin therapy. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.